Symptom-triggered medication for neonatal opioid withdrawal yields shorter hospital stays
sciencedaily | July 09, 2019
A study led by researchers at Boston Medical Center (BMC) found that symptom-triggered medication dosing for neonatal opioid withdrawal syndrome instead of infants receiving a fixed schedule of medication with a long taper reduced the length of their hospital stay.